Biotechnology Get all the latest news from the field of biotechnology and its many applications, including testing, treatment, and pharmaceuticals. This category includes research, clinical, and study results, as well as stories about the newest breakthroughs in the industry. Read stories about upcoming conferences and symposiums, along with releases regarding patents, legal activity, company performance, and market analysis.

Latest

Sep 20, 2017, 08:00 ET DURECT Appoints Dr. Myriam Theeuwes as Senior Vice President, Clinical Development

DURECT Corporation (Nasdaq: DRRX) announced today that Dr. Myriam Theeuwes has joined DURECT as Senior Vice President, Clinical Development. Dr....


Sep 20, 2017, 08:00 ET Rise in Teenage Opioid Deaths Highlights Desperate Need for Adolescent Drug Treatment

With a new federal report finding a nearly 20 percent rise in opioid-related deaths among teenagers, The Rosenthal Center for Addiction Studies...


Sep 20, 2017, 08:00 ET Xencor to Present at Upcoming Investor Conferences

Xencor, Inc. (NASDAQ: XNCR), a clinical-stage biopharmaceutical company developing engineered monoclonal antibodies for the treatment of autoimmune...


Sep 20, 2017, 08:00 ET NW BIO Announces Registered Direct Offering Of $1.75 Million

Northwest Biotherapeutics (OTCQB: NWBO) (NW Bio), a biotechnology company developing DCVax® personalized immune therapies for solid tumor cancers,...


Sep 20, 2017, 08:00 ET Protagonist Therapeutics Announces Preliminary Phase 1 Study Results with Novel Hepcidin Mimetic, PTG-300

Protagonist Therapeutics, Inc. (Nasdaq: PTGX) today announced preliminary results from the Phase 1 study of PTG-300 in normal healthy volunteers....


Sep 20, 2017, 08:00 ET Aldeyra Therapeutics to Present at the Annual Cantor Fitzgerald Global Healthcare Conference

Aldeyra Therapeutics, Inc. (NASDAQ:ALDX) (Aldeyra), a clinical-stage biotechnology company devoted to treating inflammation, inborn errors of...


Sep 20, 2017, 08:00 ET Trovagene Strengthens Board of Directors with Appointment of Oncology Development Veteran Dr. Athena Countouriotis

Trovagene, Inc. (NASDAQ: TROV), a precision medicine biotechnology company, today announced the expansion and strengthening of its Board of...


Sep 20, 2017, 08:00 ET BioSpecifics Technologies Corp. to Present at the 2017 Cantor Fitzgerald Global Healthcare Conference

BioSpecifics Technologies Corp. (NASDAQ: BSTC), a biopharmaceutical company that originated and continues to develop collagenase based-therapies...


Sep 20, 2017, 08:00 ET Roivant Sciences Launches Datavant to Improve Clinical Trials with Artificial Intelligence

Roivant Sciences, a global healthcare company focused on realizing the full value of promising biomedical research to improve the lives of patients...


Sep 20, 2017, 07:30 ET Bio-Techne Unveils a New Multi-Analyte Cartridge Format for the Ella™ Immunoassay Platform, Improving Sample Throughput

ProteinSimple®, a Bio-Techne brand, announced today an expansion of the Ella immunoassay platform with the launch of a 32x4 Simple Plex™ cartridge....


Sep 20, 2017, 07:24 ET Nektar Therapeutics Announces Seven Abstracts Accepted for Presentation at 2017 Society for Immunotherapy of Cancer (SITC) 32nd Annual Meeting

Nektar Therapeutics (Nasdaq: NKTR) today announced that new data across its wholly-owned immuno-oncology (I-O) portfolio will be presented at the...


Sep 20, 2017, 07:00 ET The Parker Institute for Cancer Immunotherapy and the Cancer Research Institute Announce First Patients Treated in Pancreatic Cancer Clinical Trial Combining Immunotherapy and Chemotherapy

The Parker Institute for Cancer Immunotherapy and the Cancer Research Institute (CRI) today announced the first patients have begun treatment in a...


Sep 20, 2017, 07:00 ET Intec Pharma to Participate in the Ladenburg Thalmann 2017 Healthcare Conference

Intec Pharma Ltd. (NASDAQ and TASE: NTEC) today announced that management will participate in the Ladenburg Thalmann 2017 Healthcare Conference to...


Sep 20, 2017, 07:00 ET OTC Markets Group Welcomes Beleave to OTCQX

OTC Markets Group Inc. (OTCQX: OTCM), operator of financial markets for 10,000 U.S. and global securities, today announced Beleave Inc. (CSE: BE;...


Sep 20, 2017, 07:00 ET Sierra Oncology to Present at the 2017 Cantor Fitzgerald Global Healthcare Conference

- "Beyond PARP - Next Generation DDR Therapeutics" scheduled for 8:35 am ET on September 26, 2017 - VANCOUVER, Sept. 20, 2017 /PRNewswire/ -...


Sep 20, 2017, 06:49 ET Edinburgh Molecular Imaging Commences Phase II European Cancer Trial

Edinburgh Molecular Imaging (EM Imaging), the clinical phase biotechnology company focused on enabling image-guided therapy, announces it has...


Sep 20, 2017, 06:35 ET Technical Reports on Biotech Equities -- Vanda Pharma, ACADIA Pharma, Achillion Pharma, and Agios Pharma

If you want a Stock Review on VNDA, ACAD, ACHN, or AGIO then come over to http://dailystocktracker.com/register/ and sign up for your free...


Sep 20, 2017, 06:25 ET Edesa Biotech Completes Financing to Develop Novel Dermatology and Anorectal Treatments

MARKHAM, ON, Sept. 20, 2017 /PRNewswire/ - Edesa Biotech Inc., a clinical-stage private company announced today the completion of a $7 million...


Sep 20, 2017, 06:04 ET PharmaMar débute des études cliniques avec un nouveau composé, PM14, chez des patients atteints de tumeurs solides

Désireux de trouver une solution aux besoins insatisfaits des patients souffrant de différents types de cancer, PharmaMar (MCE: PHM) annonce le...


Sep 20, 2017, 06:00 ET Soligenix Announces $1.5 Million NIDCR SBIR Grant Award Supporting the Pivotal Phase 3 Clinical Trial of SGX942 for the Treatment of Oral Mucositis in Head and Neck Cancer

Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing...